AIMS: The aim of the present study was to determine the prevalence of abnormal glucose tolerance and the metabolic syndrome in a cohort of previously gestational diabetic (GDM) women 4 years after delivery. METHODS: Sixty-eight prior GDM and a control group of 39 women with normal glucose tolerance during pregnancy were invited to participate in a follow-up study. RESULTS: The prevalence of diabetes, impaired glucose tolerance and impaired fasting glucose (IFG) was 21%, 16%, and 6% among prior GDM women and 0%, 15%, and 0% among controls respectively (P=0.0039). Independently of the metabolic syndrome criteria used this status was found more frequently among women with prior GDM (all P<0.05). The prevalence of the metabolic syndrome showed a dose-response relationship with the level of weight categories (P<0.005) as well as with the level of glucose intolerance (P=0.024). CONCLUSION: According to our results a disturbed carbohydrate metabolism and a clustering of cardiovascular risk factors might be observed in previous GDM women 4 years after delivery.
AIMS: The aim of the present study was to determine the prevalence of abnormal glucose tolerance and the metabolic syndrome in a cohort of previously gestational diabetic (GDM) women 4 years after delivery. METHODS: Sixty-eight prior GDM and a control group of 39 women with normal glucose tolerance during pregnancy were invited to participate in a follow-up study. RESULTS: The prevalence of diabetes, impaired glucose tolerance and impaired fasting glucose (IFG) was 21%, 16%, and 6% among prior GDM women and 0%, 15%, and 0% among controls respectively (P=0.0039). Independently of the metabolic syndrome criteria used this status was found more frequently among women with prior GDM (all P<0.05). The prevalence of the metabolic syndrome showed a dose-response relationship with the level of weight categories (P<0.005) as well as with the level of glucose intolerance (P=0.024). CONCLUSION: According to our results a disturbed carbohydrate metabolism and a clustering of cardiovascular risk factors might be observed in previous GDM women 4 years after delivery.
Authors: C Festa; L Mattei; O Bitterman; B Pintaudi; M Framarino Dei Malatesta; P Bianchi; M Trappolini; A Colatrella; A Napoli Journal: J Endocrinol Invest Date: 2018-01-24 Impact factor: 4.256
Authors: A Tranidou; T Dagklis; I Tsakiridis; A Siargkas; A Apostolopoulou; A Mamopoulos; D G Goulis; M Chourdakis Journal: J Endocrinol Invest Date: 2020-11-23 Impact factor: 4.256
Authors: Nina Rautio; Jari Jokelainen; Eeva Korpi-Hyövälti; Heikki Oksa; Timo Saaristo; Markku Peltonen; Leena Moilanen; Mauno Vanhala; Matti Uusitupa; Jaakko Tuomilehto; Sirkka Keinänen-Kiukaanniemi Journal: J Womens Health (Larchmt) Date: 2014-05-01 Impact factor: 2.681
Authors: Maleesa M Pathirana; Zohra S Lassi; Anna Ali; Margaret A Arstall; Claire T Roberts; Prabha H Andraweera Journal: Endocrine Date: 2020-09-15 Impact factor: 3.633
Authors: Claudia Maria Vilas Freire; Felipe Batista Lima Barbosa; Maria Cristina C de Almeida; Paulo Augusto Carvalho Miranda; Márcia Melo Barbosa; Anelise Impeliziere Nogueira; Milena Moreira Guimarães; Maria do Carmo Pereira Nunes; Antônio Ribeiro-Oliveira Journal: Cardiovasc Diabetol Date: 2012-05-31 Impact factor: 9.951